Filing Details

Accession Number:
0001181431-12-010871
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-22 17:39:13
Reporting Period:
2012-02-17
Filing Date:
2012-02-22
Accepted Time:
2012-02-22 17:39:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1162194 Fluidigm Corp FLDM Laboratory Analytical Instruments (3826) 770513190
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1435931 Maxwell William Smith Fluidigm Corporation
7000 Shoreline Court Suite 100
South San Francisco CA 94080
Evp, Legal Affairs & Gc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-17 2,340 $1.82 51,885 No 4 M Direct
Common Stock Disposition 2012-02-17 2,340 $15.60 49,545 No 4 S Direct
Common Stock Acquisiton 2012-02-21 660 $1.82 50,205 No 4 M Direct
Common Stock Disposition 2012-02-21 660 $15.60 49,545 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-02-17 2,340 $0.00 2,340 $1.82
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2012-02-17 70,000 $0.00 70,000 $15.49
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-02-21 660 $0.00 660 $1.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,072 2013-07-15 No 4 M Direct
70,000 2022-02-16 No 4 A Direct
18,412 2013-07-15 No 4 M Direct
Footnotes
  1. The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on September 6, 2011.
  2. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $15.6000 to $15.6125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. The shares were to be sold on February 17, 2012. Due to a trading error, these shares were not sold until February 21, 2012 at a price per share of $14.75; however, the Reporting Person will receive proceeds based upon a sale price of $15.6004, the weighted-average price per share of shares sold on February 17, 2012.
  4. The Option fully vested on April 1, 2007.
  5. 1/48 of the shares subject to the Option vested on the date of grant and 1/48 of the shares subject to the Option will vest on March 1, 2012 and each month thereafter, such that the option will be fully vested on January 1, 2016.